Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9Fatigue 8Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Hodgkin Disease 5Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lung Neoplasms 4Leukemia, Myeloid, Acute 4Congenital Abnormalities 4Colorectal Neoplasms 4Sleep Wake Disorders 3Sezary Syndrome 3Sexual Dysfunction, Physiological 3Sarcoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Lymphoma 3Leukemia, Prolymphocytic 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Mast-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Large Granular Lymphocytic 3Leukemia, Hairy Cell 3

Interventions

tremelimumab 1durvalumab 1atezolizumab 1Therapeutics 1Immunotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Unresectable Hepatocellular Carcinoma × Therapeutics × Clear all
NCT05660213 2025-05-20

A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

Fudan University

Not yet recruiting
750 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡